Full Committee Hearing FDA User Fee Agreements: Advancing Medical Product Regulation and Innovation for the Benefit of Patients, FDA Center Directors

Date: Tuesday, April 26, 2022 Time: 10:00 AM Location: 430 Dirksen Senate Office Building

Open in New Window

Witnesses

  1. Patrizia Cavazzoni, M.D.
    Director
    Center for Drug Evaluation and Research, United States Food and Drug Administration
    Silver Spring, MD
  2. Peter Marks, M.D., Ph.D
    Director
    Center for Biologics Evaluation and Research, United States Food and Drug Administration
    Silver Spring, MD
  3. Jeffrey Shuren, M.D., J.D.
    Director
    Center for Devices and Radiological Health, United States Food and Drug Administration
    Silver Spring, MD

Those in need of accommodations, including closed captioning for webcast hearings, should contact the Committee at 202-224-5375 or accessibility@help.senate.gov. So as to best enable staff to make arrangements, please call or email at least 3 business days in advance of the hearing.